Glucocil
Asset
Dietary supplement formulated to improve metabolic health and glycemic control
- Stage
- Human trials
- Modality
- Supplement
- Target
- Not known
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Pre-diabetes
Human trials, Completed, NCT06496893, clinicaltrials.gov, 7 Oct 2026
Type2 diabetes mellitus
Human trials, Completed, NCT06496893, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026, 1 source